Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1989 Dec 16;299(6714):1479–1480. doi: 10.1136/bmj.299.6714.1479

Cytotoxic drugs for gastric and colorectal cancer.

D Cunningham 1
PMCID: PMC1838392  PMID: 2514857

Full text

PDF
1479

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beer M., Cocconi G., Ceci G., Varini M., Cavalli F. A phase II study of cisplatin in advanced gastric cancer. Eur J Cancer Clin Oncol. 1983 Jun;19(6):717–720. doi: 10.1016/0277-5379(83)90003-2. [DOI] [PubMed] [Google Scholar]
  2. Cullinan S. A., Moertel C. G., Fleming T. R., Rubin J. R., Krook J. E., Everson L. K., Windschitl H. E., Twito D. I., Marschke R. F., Foley J. F. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin. JAMA. 1985 Apr 12;253(14):2061–2067. [PubMed] [Google Scholar]
  3. Cunningham D., Hawthorn J., Pople A., Gazet J. C., Ford H. T., Challoner T., Coombes R. C. Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist. Lancet. 1987 Jun 27;1(8548):1461–1463. doi: 10.1016/s0140-6736(87)92208-2. [DOI] [PubMed] [Google Scholar]
  4. Cunningham D., Hole D., Taggart D. J., Soukop M., Carter D. C., McArdle C. S. Evaluation of the prognostic factors in gastric cancer: the effect of chemotherapy on survival. Br J Surg. 1987 Aug;74(8):715–720. doi: 10.1002/bjs.1800740822. [DOI] [PubMed] [Google Scholar]
  5. Cunningham D., Soukop M., McArdle C. S., Carter D. C., Smyth J. F., Allan S. G., Kaye S. B., Sangster G., Calman K. C., Hutcheon A. W. Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C. Br J Surg. 1984 Sep;71(9):673–676. doi: 10.1002/bjs.1800710909. [DOI] [PubMed] [Google Scholar]
  6. Erlichman C., Fine S., Wong A., Elhakim T. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol. 1988 Mar;6(3):469–475. doi: 10.1200/JCO.1988.6.3.469. [DOI] [PubMed] [Google Scholar]
  7. Lacave A. J., Wils J., Diaz-Rubio E., Clavel M., Planting A., Bleiberg H., Duez N., Dalesio O. cis-Platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Eur J Cancer Clin Oncol. 1985 Nov;21(11):1321–1324. doi: 10.1016/0277-5379(85)90311-6. [DOI] [PubMed] [Google Scholar]
  8. Leichman L., McDonald B., Dindogru A., Samson M., Vaitkevicius V. K. Cisplatin. An active drug in the treatment of disseminated gastric cancer. Cancer. 1984 Jan 1;53(1):18–22. doi: 10.1002/1097-0142(19840101)53:1<18::aid-cncr2820530105>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  9. Lokich J. J., Ahlgren J. D., Gullo J. J., Philips J. A., Fryer J. G. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. J Clin Oncol. 1989 Apr;7(4):425–432. doi: 10.1200/JCO.1989.7.4.425. [DOI] [PubMed] [Google Scholar]
  10. MacDonald J. S., Woolley P. V., Smythe T., Ueno W., Hoth D., Schein P. S. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer. Cancer. 1979 Jul;44(1):42–47. doi: 10.1002/1097-0142(197907)44:1<42::aid-cncr2820440108>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  11. O'Connell M. J. A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A Mayo Clinic/North Central Cancer Treatment Group study. Cancer. 1989 Mar 15;63(6 Suppl):1026–1030. doi: 10.1002/1097-0142(19890315)63:6+<1026::aid-cncr2820631307>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  12. Petrelli N., Herrera L., Rustum Y., Burke P., Creaven P., Stulc J., Emrich L. J., Mittelman A. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol. 1987 Oct;5(10):1559–1565. doi: 10.1200/JCO.1987.5.10.1559. [DOI] [PubMed] [Google Scholar]
  13. Wagener D. J., Yap S. H., Wobbes T., Burghouts J. T., van Dam F. E., Hillen H. F., Hoogendoorn G. J., Scheerder H., van der Vegt S. G. Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer. Cancer Chemother Pharmacol. 1985;15(1):86–87. doi: 10.1007/BF00257302. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES